熱點掃描 | 小鵬汽車漲超7%領漲汽車股
uSMART盈立智投4月26日消息，截止發稿，港股三大指數齊漲，恆生指數上漲1.4%，報20148..972點，成交額502.95億；國企指數上漲2.28%，報6837.19點，成交額185.65億；紅籌指數上漲0.66%，報3802.13點，成交額21.32億。
餐飲板塊拉昇，海底撈漲超8%，呷哺呷哺漲逾7%，海倫司、九毛九漲5%，奈雪的茶漲近5%；
互聯網醫療漲幅靠前，京東健康漲超6%，阿裏健康、衆安在線漲逾4%，平安好醫生漲2.58%；
汽車股普漲，小鵬汽車漲超7%領漲，理想汽車、蔚來漲逾5%，五菱汽車、比亞迪股份漲3%，吉利汽車、廣汽集團、長城汽車跟漲；
手遊股走強，網易、家鄉互動、嗶哩嗶哩漲超7%，心動公司漲6%，飛魚科技、金山軟件、中手遊漲超4%；
熱門股
再鼎醫藥漲8.32%，報35.15港元，再鼎醫藥上週末宣佈，公司董事會批準根據香港聯交所指引信HKEX-GL112-22尋求於香港聯交所主板自願轉換爲雙重主要上市(“主要轉換”)的動議。董事會亦授權公司高級管理層進行相關準備工作，並採取必要步驟以完成主要轉換。主要轉換生效後，公司將成爲於香港聯交所主板及納斯達克全球市場雙重主要上市的公司。公司的普通股及美國存託股份將繼續分別於香港聯交所及納斯達克全球市場買賣，且仍可互換。
愛爾眼科逆勢走強，盤中一度拉昇漲近6%報35.55元，市值1921億元。愛爾眼科昨晚公佈業績顯示，2022年一季度實現營業收入41.69億元，同比增長18.72%；淨利潤6.11億元，同比增長26.15%；扣非後歸母淨利潤6.23億元，同比增長22.49%。
國盛證券稱，公司一季度保持穩健快速增長，公司在今年3月份受到疫情較大擾動的情況下，繼續延續較高的增長趨勢。國盛證券稱，愛爾的投資價值在於業績穩定高速成長帶來的稀缺性與配置價值，而這來源於愛爾新十年的國際化戰略與不斷擴張的國內業務。截至2021年底，公司海外眼科醫療機構網絡包括歐洲93家、東南亞12家、美國1家。公司國際化戰略的實施一方面將有助於獲取深度融合國際先進的醫療服務理念和最前沿的技術體系，在學術上與技術上幫助國內的品牌進一步提升，另一方面東南亞等地區也有望成爲公司未來的潛力增長空間。
招行逆勢再跌逾2%，報45.75港元，本月累計跌幅達26%，最新總市值11525億港元。富瑞最新研報稱，於內地經濟前景、貨幣寬鬆政策的推出遲過預期，以及招行可能採取更保守的撥備政策，該行下調了對招行2023年業績預測，目標價由62.72港元下調至55.3港元，維持持有評級。交銀國際發研報指，招行22年1季度淨利潤同比增長12.5%，低於21年23%的增幅。交銀認爲招行未來資產質量承壓和戰略持續性較不確定，因此將目標價從84港元下調至75港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
